Terapia CAR-T en China — reciba 3 opciones de clínicas personalizadas

CAR T-cell therapy in China typically costs from $165,000 to $275,000. Prices depend on the specific cell product used, clinical protocol, and length of hospital stay. In the United States, similar procedures cost around $525,000 on average. Patients save around 58% compared to US costs. Standard Chinese packages usually include T-cell collection, laboratory manufacturing, lymphodepletion chemotherapy, and 30 days of specialized inpatient monitoring.

• Approved commercial therapies: $165,000 to $275,000 for NMPA-cleared products like Axi-cel or Relma-cel.
• Clinical trial pathways: Often range from 15% to 40% of the cost of commercial drugs.
• Administrative hubs: Specialized treatment centers are primarily located in Beijing, Shanghai, and Guangzhou.
• Inpatient monitoring: Typically covers a 4-week stay to manage cytokine release syndrome or neurotoxicity.

Bookimed Expert Insight: China represents a unique value for refractory blood cancers due to high treatment volumes. Beijing GoBroad Boren Hospital, a top hematology specialist, offers packages starting around $100,000. This includes a full 30-day hospital stay and comprehensive diagnostics. Facilities like Fuda Cancer Hospital hold JCI accreditation, ensuring international safety standards. For complex pediatric cases, centers like Beijing Kyoto Children's Hospital provide specialized wards for high-risk management.